BIORESTORATIVE THERAPIES, INC. (BRTX)

Every figure this model derived for BRTX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-03-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 116,069 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 3,592,030 CashAndCashEquivalentsAtCarryingValue 2026-03-31
current assets 3,799,708 AssetsCurrent 2026-03-31
current liabilities 1,614,637 LiabilitiesCurrent 2026-03-31
equity 3,025,642 StockholdersEquity 2026-03-31
ocf -11,817,969 NetCashProvidedByUsedInOperatingActivities 2026-03-31
revenue 357,870 RevenueFromContractWithCustomerExcludingAssessedTax 2026-03-31
sbc 1,606,715 ShareBasedCompensation 2026-03-31

The ratios

The figures themselves rather than their scores — what somebody looking up BRTX on one particular measure came for.

RatioValue
current ratio2.59
current ratio reported2.35
deferred revenue growth-100.0
dilution pct15.84
growth cv1.45
revenue growth-8.47
revenue growth per share-20.99
rule of 40-3983.47
sbc pct revenue448.97

What to be careful about

What this model itself distrusts about BRTX's figures. Written by the derivation as it ran, not added afterwards.